ANI Pharmaceuticals
ANIP
$65.72
Share price
-0.48%
Change (1 day)
60.75%
Change (1 year)
Categories
Market capitalization of ANI Pharmaceuticals (ANIP)
Market cap: $1.40 Billion
As of May 2024 ANI Pharmaceuticals has a market cap of $1.40 Billion. This makes ANI Pharmaceuticals the world's 4739th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of ANI Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.40 B | 24.73% |
| 2023 | $1.12 B | 60.41% |
| 2022 | $0.70 B | -8.59% |
| 2021 | $0.76 B | 113.92% |
| 2020 | $0.35 B | -51.88% |
| 2019 | $0.74 B | 39.73% |
| 2018 | $0.53 B | -28.9% |
| 2017 | $0.75 B | 6.89% |
| 2016 | $0.70 B | 35.3% |
| 2015 | $0.51 B | -19.2% |
| 2014 | $0.64 B | 232.38% |
| 2013 | $0.19 B | 542.06% |
| 2012 | $30.11 M | -45.47% |
| 2011 | $55.23 M | -58.82% |
| 2010 | $0.13 B | 72.4% |
| 2009 | $77.79 M | 183.58% |
| 2008 | $27.43 M | -73.3% |
| 2007 | $0.10 B | 58.77% |
| 2006 | $64.72 M | -8.59% |
| 2005 | $70.8 M | -33.21% |
| 2004 | $0.10 B | 83.53% |
| 2003 | $57.76 M | 101.18% |
| 2002 | $28.71 M | -46.57% |
| 2001 | $53.73 M |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of ANI Pharmaceuticals was reported to be:
$1.38 Billion
$1.38 Billion
$1.39 Billion
$1.38 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $211.09 B | 14,925.94% | 🇨🇭 Switzerland |
 Pfizer PFE | $164.50 B | 11,610.21% | 🇺🇸 USA |
 Cardinal Health CAH | $23.96 B | 1,605.54% | 🇺🇸 USA |
 Jazz Pharmaceuticals JAZZ | $7.02 B | 400.26% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | $4.03 M | -99.71% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $2.72 B | 93.95% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $19.07 B | 1,257.71% | 🇮🇱 Israel |
 Royalty Pharma RPRX | $17.09 B | 1,117.02% | 🇬🇧 UK |
 Lannett Company LCI | $7.38 M | -99.47% | 🇺🇸 USA |